San Diego-primarily based Viking Therapeutics marked alone as a significant competitor during the weight loss drug marketplace in February after revealing promising info from a mid-stage demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when specified as a weekly injection As well as in March t